A Study Evaluating the Impact of Regular FODMAP-targeting Digestive Enzyme Blend Use on Gastrointestinal Symptoms in Individuals With Self-Reported Bloating | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study Evaluating the Impact of Regular FODMAP-targeting Digestive Enzyme Blend Use on Gastrointestinal Symptoms in Individuals With Self-Reported Bloating	Abdominal Pain, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Skin and Connective Tissue Diseases, colonic disorder, connective tissue disorder, cutaneous mucinosis, digestive system disorder, functional colonic disease, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, intestinal disorder, irritable bowel syndrome, lysosomal storage disease, metabolic disease, mucopolysaccharidosis, mucopolysaccharidosis type 4	Recruiting	Not applicable	2026-05-15		NCT07591584

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Kiwi Health Inc	1
People Science, Inc.	15

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
People Science	Los Angeles	United States	2